Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan.
Eur Spine J. 2012 Jun;21(6):1178-85. doi: 10.1007/s00586-011-2129-3. Epub 2011 Dec 27.
A procedure using an interspinous process spacer (IPS) was recently developed for the treatment of posture-dependent lumbar spinal-canal stenosis (LSS) patients. We developed a novel IPS which can be inserted with simpler procedures and removed percutaneously. The objectives of this study were: (1) to evaluate the feasibility and safety of this novel technique, and (2) to assess the effectiveness of this spacer in terms of preventing an increase of epidural pressure in lumbar extension using a porcine model.
Eight young pigs were used. Under general anesthesia and image guidance, the spacers were inserted. Three months after operation, MR images were taken and all spacers were removed. Blood samples were obtained before and 1, 3, 7 days after surgery. After killing the animals, the lumbar spines were observed macroscopically. Another six animals were used. Under general anesthesia and image guidance, a flexible pressure transducer was inserted into the epidural space and epidural pressure was measured in neutral and at maximum extension with and without spacer insertion.
Percutaneous insertion and removal of the spacer was successful for all animals through small skin incisions. MR images showed minimal damage to the muscle. No significant up-regulation of Interleukin-6 (IL-6) and CRP was detected. Macroscopic observation of the lumbar spine 3 months after the operation revealed that the area of the interspinous process contacting with the inserted spacer showed some bone erosion/remodeling. Insertion of the spacer did not affect the epidural pressure in neutral but significantly prevented an increase of epidural pressure in lumber extension.
This study demonstrated that the percutaneous insertion and removal of a novel IPS was feasible and safe using a simple technique. Furthermore, this procedure can be recognized as minimally invasive surgery from the viewpoint of skin incision, short insertion track, inflammatory mediators, and muscle damage. Improvements should be attempted in future studies using softer or more elastic materials for the spacer to lessen bone erosion/remodeling at contacting area of the inserted spacer.
最近开发了一种使用棘突间间隔物(IPS)的程序来治疗体位依赖性腰椎管狭窄症(LSS)患者。我们开发了一种新型 IPS,其可以通过更简单的程序插入,并通过经皮方式取出。本研究的目的是:(1)评估该新型技术的可行性和安全性,(2)使用猪模型评估该间隔物在预防腰椎伸展时硬膜外压力增加方面的有效性。
使用 8 头小猪。在全身麻醉和图像引导下插入间隔物。手术后 3 个月,进行 MRI 检查,并取出所有间隔物。在手术前、手术后第 1、3、7 天采集血样。处死动物后,观察腰椎的大体情况。另外使用 6 只动物。在全身麻醉和图像引导下,将柔性压力传感器插入硬膜外间隙,在插入和不插入间隔物的情况下,在中立位和最大伸展位测量硬膜外压力。
所有动物均通过小切口成功进行了经皮插入和取出间隔物。MRI 图像显示肌肉损伤最小。未检测到白细胞介素-6(IL-6)和 CRP 的显著上调。术后 3 个月观察腰椎大体情况显示,与插入间隔物接触的棘突间区域出现一些骨质侵蚀/重塑。插入间隔物不影响中立位的硬膜外压力,但可显著防止腰椎伸展时硬膜外压力增加。
本研究表明,使用简单的技术,经皮插入和取出新型 IPS 是可行且安全的。此外,从皮肤切口、插入轨迹短、炎症介质和肌肉损伤的角度来看,该手术可被视为微创手术。未来的研究应尝试使用更柔软或更有弹性的材料来改进间隔物,以减轻插入间隔物接触区域的骨质侵蚀/重塑。